Artificial intelligence (AI) can analyze a large amount of clinical data in a short period of time, assist doctors in judging, classifying and processing, and greatly shorten the clinical strain time, and secondly improve the accuracy of medical care. According to reports, the Royal Liverpool and Broadgreen University Hospitals NHS Trust announced that it has partnered with AI's new DeonTIcs to help physicians make clinical decisions and reduce the risk of heart disease. In order to meet the special needs of patients, the hospital's acute heart disease (ACU) doctors will use AI clinical treatment recommendations, which are based on guidelines from regulatory agencies such as the National Institute of Health and Care Excellence (NICE) to reduce patients. The risk of bleeding and heart disease recurrence. This cooperation is expected to improve the quality of care, improve recovery and reduce the number of hospital stays. The hospital's clinical information chief Mike Fisher said that a few of the weakest and oldest patients with acute coronary heart disease are taking the most potent drugs, and AI can prevent doctors from giving excessive amounts of medication to patients and provide appropriate treatment. In the summer of 2018, the acute heart disease room will use the DeonTIcs AI technology, but initially it will only be connected to the electronic record system, and it is expected to connect to other clinical systems, such as the electronic medical record system. DeonTIcs decision support tools provide chemotherapy recommendations based on complex research. DeonTIcs CEO Guy Wood-Gush said that they have been working with physicians for many years to develop an AI platform that meets the needs of physicians. The Deontics AI technology can indeed improve patient safety and provide high quality and cost-effective medical care. Ningbo Autrends International Trade Co.,Ltd. , https://www.vapee-cigarettes.com